Raised S.B. No. 138
Session Year 2020


AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.


Other Bills with Similar Topics

  Drugs 

  Unfair or deceptive trade practices 

  Pharmaceutical manufacturing companies